Israel Englander Horizon Therapeutics Public LTD CO Call Options Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $68 Million - $79.4 Million	706,100 Added 1272.25%	761,600 $78.3 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $132 Million - $139 Million	-1,229,000 Reduced 95.68%	55,500 $6.06 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $80.1 Million - $146 Million	1,284,500 New	1,284,500 $146 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.